Rezolute (RZLT) Cost of Revenue (2013 - 2021)
Rezolute's (RZLT) quarterly Cost of Revenue came in at $204000.0 in Q2 2021, up 29.94% year-on-year from $157000.0 in Q2 2020, and down 19.37% quarter-over-quarter from $253000.0 in Q1 2021.
Rezolute (RZLT) Cost of Revenue (2013 - 2021) Analysis & Trends
Rezolute has disclosed Cost of Revenue across 9 years of filings, most recently posting $204000.0 for Q2 2021.
- Cost of Revenue for Q2 2021 came in at $204000.0, up 29.94% year-over-year; the trailing twelve-month figure through Jun 2021 was $765000.0 (down 13.27% YoY), and the FY2021 annual result was $765000.0, down 13.27% from the prior year.
- Cost of Revenue came in at $204000.0 for Q2 2021 at Rezolute, down from $253000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $678000.0 in Q2 2019 to a low of $9000.0 in Q1 2019.
- The 5-year median for Cost of Revenue is $227602.0 (2017), against an average of $268488.6.
- Across the five-year window, Cost of Revenue slumped 95.89% in 2019 and jumped 3055.56% in 2020, its largest moves.
- Rezolute's Cost of Revenue stood at $227602.0 in 2017, then soared by 107.38% to $472000.0 in 2018, then slumped by 46.19% to $254000.0 in 2019, then tumbled by 47.24% to $134000.0 in 2020, then soared by 52.24% to $204000.0 in 2021.
- The last three Cost of Revenue figures came in at $204000.0 (Q2 2021), $253000.0 (Q1 2021), and $134000.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 2.05 Mn |
| 10 | Rezolute | 425.23 Mn | 425.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 204,000.00 |
| Jun 30, 2021 | 204,000.00 |
| Mar 31, 2021 | 253,000.00 |
| Mar 31, 2021 | 253,000.00 |
| Dec 31, 2020 | 134,000.00 |
| Dec 31, 2020 | 134,000.00 |
| Sep 30, 2020 | 174,000.00 |
| Sep 30, 2020 | 174,000.00 |
| Jun 30, 2020 | 157,000.00 |
| Jun 30, 2020 | 157,000.00 |
| Mar 31, 2020 | 284,000.00 |
| Mar 31, 2020 | 284,000.00 |
| Dec 31, 2019 | 254,000.00 |
| Dec 31, 2019 | 254,000.00 |
| Sep 30, 2019 | 187,000.00 |
| Sep 30, 2019 | 187,000.00 |
| Jun 30, 2019 | 678,000.00 |
| Jun 30, 2019 | 678,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Mar 31, 2019 | 9,000.00 |